25 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... condition #IDSA ... Antimicrobials #Empiric #Coverage ... InfectiousDiseases #Pharmacology ... #Management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Mycobacterium tuberculosis ... Opportunistic #Infections #OIs ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Mycobacterium tuberculosis ... Opportunistic #Infections #OIs ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Multidrug-Resistant Tuberculosis ... #MDRTB #management ... antimicrobials #pharmacology ... #dosing #idsa #
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
and Children - IDSA ... Moxifloxacin #Tuberculosis ... #Medications #management ... #pharmacology #
Cephalosporins - Table of Coverage by Generation

1st Generation   Cefazolin, cephalexin 
2nd Generation Cefotetan 
3rd
Cephalosporins - Table of Coverage ... Cefoperazone is ... Cephalosporins #Coverage ... #Ceftaroline #Pharmacology ... Antibiotics #Table #Management
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
fluconazole; ISA ... #antibiogram #management ... #pharmacology # ... spectrum #coverage
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
pneumococcal resistance is ... fluoroquinolone #IDSA ... Treatment #Regimen #Management ... #Guidelines #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Multi-Drug Resistant Tuberculosis ... #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... multidrug-resistant tuberculosis ... #MDRTB #management ... antimicrobials #pharmacology ... #ebm #idsa